600211 西藏药业
已收盘 08-06 15:00:00
资讯
新帖
简况
股市必读:西藏药业新发布《西藏诺迪康药业股份有限公司关于回购股份的进展公告》
证券之星 · 08-05 01:36
股市必读:西藏药业新发布《西藏诺迪康药业股份有限公司关于回购股份的进展公告》
西藏药业(600211)披露回购股份进展公告,8月3日股价上涨0.96%
证券之星 · 08-03
西藏药业(600211)披露回购股份进展公告,8月3日股价上涨0.96%
每周股票复盘:西藏药业(600211)担保总额14.2亿占净资产34.32%
证券之星 · 07-19
每周股票复盘:西藏药业(600211)担保总额14.2亿占净资产34.32%
西藏药业(600211)披露为控股子公司提供担保进展公告,7月15日股价上涨1.96%
证券之星 · 07-15
西藏药业(600211)披露为控股子公司提供担保进展公告,7月15日股价上涨1.96%
每周股票复盘:西藏药业(600211)回购进展支付近1.78亿元
证券之星 · 07-05
每周股票复盘:西藏药业(600211)回购进展支付近1.78亿元
西藏药业(600211)披露回购股份进展公告,7月1日股价上涨2.65%
证券之星 · 07-01
西藏药业(600211)披露回购股份进展公告,7月1日股价上涨2.65%
西藏药业涨6.74%,华鑫证券二个月前给出“买入”评级
证券之星 · 06-29
西藏药业涨6.74%,华鑫证券二个月前给出“买入”评级
西藏药业:生产端智能化升级已成为公司降本增效、强化产品质量的重要方向
证券之星 · 06-24
西藏药业:生产端智能化升级已成为公司降本增效、强化产品质量的重要方向
西藏药业:公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索
证券之星 · 06-24
西藏药业:公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索
西藏药业(600211)披露回购股份进展公告,6月1日股价下跌0.36%
证券之星 · 06-01
西藏药业(600211)披露回购股份进展公告,6月1日股价下跌0.36%
每周股票复盘:西藏药业(600211)每股派现0.876元
证券之星 · 05-17
每周股票复盘:西藏药业(600211)每股派现0.876元
西藏药业(600211)披露2025年年度权益分派实施公告,5月14日股价下跌1.49%
证券之星 · 05-14
西藏药业(600211)披露2025年年度权益分派实施公告,5月14日股价下跌1.49%
每周股票复盘:西藏药业(600211)回购耗资1.78亿用于股权激励
证券之星 · 05-10
每周股票复盘:西藏药业(600211)回购耗资1.78亿用于股权激励
西藏药业(600211)披露回购股份进展公告,5月8日股价上涨0.33%
证券之星 · 05-08
西藏药业(600211)披露回购股份进展公告,5月8日股价上涨0.33%
每周股票复盘:西藏药业(600211)Q1净利增10.93%
证券之星 · 05-02
每周股票复盘:西藏药业(600211)Q1净利增10.93%
西藏药业(600211)3月31日股东户数4.31万户,较上期增加0.7%
证券之星 · 04-28
西藏药业(600211)3月31日股东户数4.31万户,较上期增加0.7%
每周股票复盘:西藏药业(600211)华西药业质押展期1,876万股
证券之星 · 04-19
每周股票复盘:西藏药业(600211)华西药业质押展期1,876万股
中国经济网报道 | 扎根雪域守初心 锚定双径谋发展 西藏药业勇担“西藏的药业”时代使命
市场资讯 · 04-16
中国经济网报道 | 扎根雪域守初心 锚定双径谋发展 西藏药业勇担“西藏的药业”时代使命
每周股票复盘:西藏药业(600211)将召开2025年年度股东会
证券之星 · 04-12
每周股票复盘:西藏药业(600211)将召开2025年年度股东会
西藏药业(600211)披露2025年年度股东会召开提示性公告,4月7日股价下跌0.19%
证券之星 · 04-07
西藏药业(600211)披露2025年年度股东会召开提示性公告,4月7日股价下跌0.19%
加载更多
公司概况
公司名称:
西藏诺迪康药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-07-21
主营业务:
西藏诺迪康药业股份有限公司的主营业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司的主要产品是新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒。近年来,公司先后荣获“西藏自治区专精特新中小企业”“主板上市公司价值100强”“农业产业化国家重点龙头企业”、中国创新药价值排行榜双榜:“综合实力榜TOP50”与“生物药榜TOP20”“2025大健康卓越竞争力上市公司”,连续荣获“金牛最具投资价值奖”“上市公司董事会秘书履职评价4A评级”等多项荣誉。
发行价格:
6.00
{"stockData":{"symbol":"600211","market":"SH","secType":"STK","nameCN":"西藏药业","latestPrice":37.91,"timestamp":1785999601000,"preClose":38.6,"halted":0,"volume":3319810,"delay":0,"changeRate":-0.0179,"floatShares":322000000,"shares":322000000,"eps":3.0013,"marketStatus":"已收盘","change":-0.69,"latestTime":"08-06 15:00:00","open":38.62,"high":38.83,"low":37.8,"amount":126000000,"amplitude":0.0267,"askPrice":37.92,"askSize":46,"bidPrice":37.91,"bidSize":2,"shortable":0,"etf":0,"ttmEps":3.0013,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786066200000},"marketStatusCode":5,"adr":0,"adjPreClose":38.6,"symbolType":"stock","openAndCloseTimeList":[[1785979800000,1785987000000],[1785992400000,1785999600000]],"highLimit":42.46,"lowLimit":34.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":322319196,"isCdr":false,"pbRate":3.13,"roa":"--","peRate":12.631193,"roe":"7.58%","epsLYR":2.91,"committee":0.48583,"marketValue":12219000000,"turnoverRate":0.0103,"status":1,"floatMarketCap":12219000000},"requestUrl":"/m/hq/s/600211","defaultTab":"news","newsList":[{"id":"2657563387","title":"股市必读:西藏药业新发布《西藏诺迪康药业股份有限公司关于回购股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657563387?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:36","pubTimestamp":1785864972,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年7月底,西藏药业累计回购股份4,000,058股,占总股本1.24%,已支付177,595,651.46元;2026年7月未实施回购。公司公告汇总西藏诺迪康药业股份有限公司关于回购股份的进展公告西藏诺迪康药业股份有限公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。回购股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600211","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656639377","title":"西藏药业(600211)披露回购股份进展公告,8月3日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656639377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656639377?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:27","pubTimestamp":1785767237,"startTime":"0","endTime":"0","summary":"近日,西藏诺迪康药业股份有限公司发布关于回购股份的进展公告。公告显示,公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。截至2026年7月底,公司累计回购股份4,000,058股,占总股本的1.24%,已支付总金额177,595,651.46元,回购价格区间为42.66元/股至45.98元/股。回购股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652123705","title":"每周股票复盘:西藏药业(600211)担保总额14.2亿占净资产34.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652123705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652123705?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:59","pubTimestamp":1784397548,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,西藏药业报收于38.3元,较上周的38.03元上涨0.71%。本周,西藏药业7月15日盘中最高价报40.7元。西藏药业当前最新总市值123.45亿元,在生物制品板块市值排名20/50,在两市A股市值排名1425/5199。公司公告汇总:本次为子公司提供担保合计11859.17万元,均在已审批额度内。本次担保金额分别为7000万元和4859.17万元,合计11859.17万元。截至公告日,公司及控股子公司对外担保总额为14.2亿元,占最近一期经审计净资产的34.32%,无逾期担保,担保风险可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651597724","title":"西藏药业(600211)披露为控股子公司提供担保进展公告,7月15日股价上涨1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651597724","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651597724?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:46","pubTimestamp":1784108795,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘,西藏药业报收于40.07元,较前一交易日上涨1.96%,最新总市值为129.15亿元。近日,西藏诺迪康药业股份有限公司发布关于为控股子公司提供担保的进展公告。截至公告日,公司及控股子公司对外担保总额为14.2亿元,占最近一期经审计净资产的34.32%,无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500034336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938692","title":"每周股票复盘:西藏药业(600211)回购进展支付近1.78亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649938692?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:54","pubTimestamp":1783194851,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,西藏药业报收于38.78元,较上周的35.6元上涨8.93%。本周,西藏药业7月2日盘中最高价报39.43元。截至2026年6月底,公司累计回购股份4,000,058股,占总股本的1.24%,已支付金额177,595,651.46元,回购最高价为45.98元/股,最低价为42.66元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648159544","title":"西藏药业(600211)披露回购股份进展公告,7月1日股价上涨2.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648159544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648159544?lang=zh_cn&edition=full","pubTime":"2026-07-01 23:12","pubTimestamp":1782918738,"startTime":"0","endTime":"0","summary":"近日,西藏诺迪康药业股份有限公司发布《关于回购股份的进展公告》。公告显示,公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。截至2026年6月底,公司累计回购股份4,000,058股,占总股本的1.24%,已支付金额177,595,651.46元,回购最高价为45.98元/股,最低价为42.66元/股。回购股份将用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647246123","title":"西藏药业涨6.74%,华鑫证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647246123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647246123?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:28","pubTimestamp":1782721724,"startTime":"0","endTime":"0","summary":"今日西藏药业涨6.74%,收盘报38.0元。2026年4月12日,华鑫证券研究员胡博新,吴景欢发布了对西藏药业的研报《公司事件点评报告:存量业务稳健增长,布局创新药打造第二增长曲线》,该研报对西藏药业给出“买入”评级。维持“买入”投资评级。西藏药业个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645993458","title":"西藏药业:生产端智能化升级已成为公司降本增效、强化产品质量的重要方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2645993458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645993458?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:30","pubTimestamp":1782293442,"startTime":"0","endTime":"0","summary":"请问两点:1. 公司是否已布局自动化生产设备与智能车间,结合AI实现生产全流程智能化管控?生产端智能化升级已成为公司降本增效、强化产品质量的重要方向。未来,公司将在现有基础上持续结合AI技术,对生产及质量管理体系进行优化升级,进一步提升运营效率与产品一致性,巩固质量竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400031958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645899851","title":"西藏药业:公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索","url":"https://stock-news.laohu8.com/highlight/detail?id=2645899851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645899851?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:27","pubTimestamp":1782293245,"startTime":"0","endTime":"0","summary":"请问两点:1. 目前AI在营销、管理、质控等环节是否已实现降本提效?公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索,提升了运营效率和管理水平。后续公司将持续深化数字化建设、AI赋能公司精益化管理,为提质增效注入新动能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400031770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640295055","title":"西藏药业(600211)披露回购股份进展公告,6月1日股价下跌0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640295055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640295055?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:21","pubTimestamp":1780323678,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,西藏药业报收于38.4元,较前一交易日下跌0.36%,最新总市值为123.77亿元。近日,西藏药业发布《关于回购股份的进展公告》。公告显示,2025年12月18日,公司董事会审议通过回购股份方案,拟使用自有资金不低于17,000万元、不高于20,000万元,通过集中竞价交易方式回购股份,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。本次回购股份用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636906273","title":"每周股票复盘:西藏药业(600211)每股派现0.876元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636906273","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636906273?lang=zh_cn&edition=full","pubTime":"2026-05-17 05:01","pubTimestamp":1778965274,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,西藏药业报收于42.24元,较上周的41.94元上涨0.72%。本周,西藏药业5月12日盘中最高价报44.5元。本周关注点公司公告汇总:西藏药业每股派发现金红利0.876元(含税),股权登记日为2026年5月21日。公司公告汇总西藏诺迪康药业股份有限公司2025年年度权益分派实施公告:每股现金红利0.876元(含税),股权登记日为2026年5月21日,除权(息)日及现金红利发放日均为2026年5月22日。现金红利发放对象为股权登记日在册的全体A股股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635452887","title":"西藏药业(600211)披露2025年年度权益分派实施公告,5月14日股价下跌1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635452887","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635452887?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:25","pubTimestamp":1778768716,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘,西藏药业报收于42.22元,较前一交易日下跌1.49%,最新总市值为136.08亿元。该股当日开盘42.72元,最高43.3元,最低42.16元,成交额达1.51亿元,换手率为1.1%。近日,西藏诺迪康药业股份有限公司发布《2025年年度权益分派实施公告》:每股现金红利0.876元(含税),股权登记日为2026年5月21日,除权(息)日及现金红利发放日均为2026年5月22日。现金红利发放对象为股权登记日在册的全体A股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634414960","title":"每周股票复盘:西藏药业(600211)回购耗资1.78亿用于股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2634414960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634414960?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:32","pubTimestamp":1778351532,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,西藏药业报收于41.94元,较上周的40.46元上涨3.66%。本周,西藏药业5月8日盘中最高价报42.4元。本周关注点公司公告汇总:已累计回购4,0058股,支付金额177,595,651.46元,用于员工持股或股权激励。2026年4月未实施回购。本次回购股份将用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600211","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431329","title":"西藏药业(600211)披露回购股份进展公告,5月8日股价上涨0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633431329?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:37","pubTimestamp":1778233046,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,西藏药业报收于41.94元,较前一交易日上涨0.33%,最新总市值为135.18亿元。近日,西藏药业发布《关于回购股份的进展公告》。公告显示,2025年12月18日,公司召开董事会审议通过回购股份方案,拟使用自有资金不低于17,000万元、不高于20,000万元,通过集中竞价交易方式回购股份,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。本次回购股份用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632476406","title":"每周股票复盘:西藏药业(600211)Q1净利增10.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632476406","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632476406?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:15","pubTimestamp":1777666512,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,西藏药业报收于40.46元,较上周的40.82元下跌0.88%。本周,西藏药业4月29日盘中最高价报41.6元。本周关注点来自业绩披露要点:西藏药业2026年一季报显示归母净利润2.99亿元,同比上升10.93%。股本股东变化股东户数变动截至2026年3月31日,西藏药业股东户数为4.31万户,较2月28日增加301.0户,增幅0.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630374838","title":"西藏药业(600211)3月31日股东户数4.31万户,较上期增加0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630374838","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630374838?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:31","pubTimestamp":1777368705,"startTime":"0","endTime":"0","summary":"证券之星消息,近日西藏药业披露,截至2026年3月31日公司股东户数为4.31万户,较2月28日增加301.0户,增幅为0.7%。在生物制品行业个股中,西藏药业股东户数高于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.56万户。从股价来看,2026年2月28日至2026年3月31日,西藏药业区间跌幅为4.7%,在此期间股东户数增加301.0户,增幅为0.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800051260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628725759","title":"每周股票复盘:西藏药业(600211)华西药业质押展期1,876万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628725759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628725759?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:12","pubTimestamp":1776539529,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,西藏药业报收于41.89元,较上周的42.26元下跌0.88%。本周,西藏药业4月15日盘中最高价报42.63元。4月14日盘中最低价报40.89元。西藏药业当前最新总市值135.02亿元,在生物制品板块市值排名23/51,在两市A股市值排名1554/5198。本次股份质押展期1,876万股,占其所持股份的33.41%,占公司总股本的5.82%。截至公告日,华西药业累计质押股份1,876万股,无限售和冻结情况。华西药业生产经营正常,具备履约能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627429322","title":"中国经济网报道 | 扎根雪域守初心 锚定双径谋发展 西藏药业勇担“西藏的药业”时代使命","url":"https://stock-news.laohu8.com/highlight/detail?id=2627429322","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627429322?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:52","pubTimestamp":1776329520,"startTime":"0","endTime":"0","summary":"(来源:西藏药业)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-04-16/doc-inhusvkh1594771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0033","BK4585","KWEB","ASHS","BK4614","ASHR","HXC","LU0963586101.USD","DRAG","BK4504","BK4588","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626812217","title":"每周股票复盘:西藏药业(600211)将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2626812217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2626812217?lang=zh_cn&edition=full","pubTime":"2026-04-12 02:04","pubTimestamp":1775930653,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,西藏药业报收于42.26元,较上周的42.0元上涨0.62%。本周,西藏药业4月10日盘中最高价报42.77元。西藏药业当前最新总市值136.21亿元,在生物制品板块市值排名23/51,在两市A股市值排名1502/5196。公司公告汇总西藏诺迪康药业股份有限公司将于2026年4月13日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式,股权登记日为2026年4月2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600211","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625995939","title":"西藏药业(600211)披露2025年年度股东会召开提示性公告,4月7日股价下跌0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625995939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625995939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:40","pubTimestamp":1775554833,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,西藏药业报收于41.92元,较前一交易日下跌0.19%,最新总市值为135.12亿元。该股当日开盘42.04元,最高42.62元,最低41.3元,成交额达1.02亿元,换手率为0.75%。西藏诺迪康药业股份有限公司于近日发布《关于召开2025年年度股东会的提示性公告》。公告显示,公司定于2026年4月13日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式,股权登记日为2026年4月2日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786042938063,"stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":0.009},{"period":"3month","weight":-0.0766},{"period":"6month","weight":-0.0946},{"period":"1year","weight":-0.0631},{"period":"ytd","weight":-0.0899}],"compareEarnings":[{"period":"1week","weight":0.0251},{"period":"1month","weight":-0.0225},{"period":"3month","weight":-0.0669},{"period":"6month","weight":-0.0406},{"period":"1year","weight":0.0733},{"period":"ytd","weight":-0.0173}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏诺迪康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"43143人(较上一季度增加0.70%)","perCapita":"7470股","listingDate":"1999-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区A区广州路3号","registeredCapital":"32231万元","survey":" 西藏诺迪康药业股份有限公司的主营业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司的主要产品是新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒。近年来,公司先后荣获“西藏自治区专精特新中小企业”“主板上市公司价值100强”“农业产业化国家重点龙头企业”、中国创新药价值排行榜双榜:“综合实力榜TOP50”与“生物药榜TOP20”“2025大健康卓越竞争力上市公司”,连续荣获“金牛最具投资价值奖”“上市公司董事会秘书履职评价4A评级”等多项荣誉。","listedPrice":6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西藏药业,600211,西藏药业股票,西藏药业股票老虎,西藏药业股票老虎国际,西藏药业行情,西藏药业股票行情,西藏药业股价,西藏药业股市,西藏药业股票价格,西藏药业股票交易,西藏药业股票购买,西藏药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}